| Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis JD Rothstein, G Tsai, RW Kuncl, L Clawson, DR Cornblath, DB Drachman, ... Annals of neurology 28 (1), 18-25, 1990 | 865 | 1990 |
| D-serine added to antipsychotics for the treatment of schizophrenia G Tsai, P Yang, LC Chung, N Lange, JT Coyle Biological psychiatry 44 (11), 1081-1089, 1998 | 825 | 1998 |
| Glutamatergic mechanisms in schizophrenia G Tsai, JT Coyle Annual review of pharmacology and toxicology 42 (1), 165-179, 2002 | 762 | 2002 |
| Central nervous pathway for acupuncture stimulation: localization of processing with functional MR imaging of the brain—preliminary experience MT Wu, JC Hsieh, J Xiong, CF Yang, HB Pan, YCI Chen, G Tsai, ... Radiology 212 (1), 133-141, 1999 | 648 | 1999 |
| Abnormal excitatory neurotransmitter metabolism in schizophrenic brains G Tsai, LA Passani, BS Slusher, R Carter, L Baer, JE Kleinman, JT Coyle Archives of general psychiatry 52 (10), 829-836, 1995 | 622 | 1995 |
| Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia JT Coyle, G Tsai, D Goff Annals of the New York Academy of Sciences 1003 (1), 318-327, 2003 | 568 | 2003 |
| The glutamatergic basis of human alcoholism. G Tsai, DR Gastfriend, JT Coyle The American journal of psychiatry 152 (3), 332-340, 1995 | 557 | 1995 |
| A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia DC Goff, G Tsai, J Levitt, E Amico, D Manoach, DA Schoenfeld, ... Archives of general psychiatry 56 (1), 21-27, 1999 | 539 | 1999 |
| N-acetylaspartate in neuropsychiatric disorders G Tsai, JT Coyle Progress in neurobiology 46 (5), 531-540, 1995 | 522 | 1995 |
| The role of glutamatergic neurotransmission in the pathophysiology of alcoholism G Tsai, JT Coyle Annual review of medicine 49 (1), 173-184, 1998 | 512 | 1998 |
| Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia G Tsai, HY Lane, P Yang, MY Chong, N Lange Biological psychiatry 55 (5), 452-456, 2004 | 445 | 2004 |
| Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. DC Goff, G Tsai, DS Manoach, JT Coyle The American journal of psychiatry 152 (8), 1213-1215, 1995 | 330 | 1995 |
| The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia JT Coyle, G Tsai Psychopharmacology 174, 32-38, 2004 | 315 | 2004 |
| Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia G Tsai, DC Goff, RW Chang, J Flood, L Baer, JT Coyle American Journal of Psychiatry 155 (9), 1207-1213, 1998 | 298 | 1998 |
| Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis PY Lin, G Tsai Biological psychiatry 55 (10), 1023-1030, 2004 | 268 | 2004 |
| Gene knockout of glycine transporter 1: characterization of the behavioral phenotype G Tsai, RJ Ralph-Williams, M Martina, R Bergeron, J Berger-Sweeney, ... Proceedings of the National Academy of Sciences 101 (22), 8485-8490, 2004 | 252 | 2004 |
| D-cycloserine added to clozapine for patients with schizophrenia. DC Goff, G Tsai, DS Manoach, J Flood, DG Darby, JT Coyle The American journal of psychiatry 153 (12), 1628-1630, 1996 | 244 | 1996 |
| Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia HY Lane, CL Huang, PL Wu, YC Liu, YC Chang, PY Lin, PW Chen, G Tsai Biological psychiatry 60 (6), 645-649, 2006 | 224 | 2006 |
| Platelet serotonin, a possible marker for familial autism J Piven, G Tsai, E Nehme, JT Coyle, GA Chase, SE Folstein Journal of Autism and Developmental Disorders 21 (1), 51-59, 1991 | 205 | 1991 |
| Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance SYT Cherlyn, P San Woon, JJ Liu, WY Ong, GC Tsai, K Sim Neuroscience & Biobehavioral Reviews 34 (6), 958-977, 2010 | 192 | 2010 |
